Affordable Access

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

Authors
  • 1
Type
Published Article
Journal
Journal of the National Cancer Institute
1460-2105
Publication Date
Volume
97
Issue
17
Pages
1262–1271
Identifiers
PMID: 16145047
Source
Medline

Abstract

Letrozole after tamoxifen is well-tolerated and improves both disease-free and distant disease-free survival but not overall survival, except in node-positive patients.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F